# Limited Competition for the Continuation of Clinical Sites for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-ns-23-004-limited-competition-for-the-continuation-of-clinical-sites/  
Official notice: https://www.grants.gov/search-results-detail/342687

> National Institutes of Health offered grants of up to $400,000 to state and local governments and tribes. Applications closed on September 2, 2022.

| Field | Value |
|---|---|
| Opportunity number | RFA-NS-23-004 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | September 2, 2022 |
| Award ceiling | $400,000 |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.172, 93.853 |

## Who can apply

- Independent school districts
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Regional Organizations; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

## What the grant funds

The purpose of this Limited Competition Funding Opportunity Announcement is to allow Undiagnosed Diseases Network (UDN) Clinical Sites that received an NIH award under RFA-RM-17-019 an opportunity to compete for one additional year of NIH funding to: continue their participation in the UDN; establish collaborations and efficient processes with the next phase Data Management and Coordinating Center (DMCC; see: RFA-NS-22-051); enroll and evaluate new participants; and further develop their sustainability plans.

## Questions people ask

### Is RFA-NS-23-004 still open?

No. It closed on September 2, 2022.

### Who can apply for Limited Competition for the Continuation of Clinical Sites for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from state and local governments and tribes. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Limited Competition for the Continuation of Clinical Sites for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed)?

Closed September 2, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $400,000 each.

### Who has been funded under RFA-NS-23-004?

NIH RePORTER lists 11 projects funded under RFA-NS-23-004 in fiscal 2023, at 11 institutions. The most were at Duke University, University of Washington, Baylor College of Medicine.

### Who has won Human Genome Research grants before?

The largest recipients over five fiscal years were The Leland Stanford Junior University, University of Washington, The Broad Institute, Inc. The program made 1,255 awards worth $2.2 billion in that time.